May 8, 2023
The University of Cincinnati's Jiajie Diao and Yujie Sun led recently published research showing the use of a new cellular probe helped discover new findings about certain cellular processes.
January 10, 2023
Krushna Patra is the first University of Cincinnati researcher to receive the prestigious National Cancer Institute MERIT Award to continue his research on how mutations help pancreatic cancer grow.
November 27, 2023
Local 12 recently spoke with the University of Cincinnati's Andrew Waters and Pancreatic Cancer Action Network volunteers to discuss ongoing pancreatic cancer research and funding support during Pancreatic Cancer Awareness Month.
January 17, 2024
The University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska, MD, PhD, has been awarded a five-year, $2.8 million grant from the National Institutes of Health to investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.
March 6, 2024
University of Cincinnati Cancer Center researchers in the lab of Jun-Lin Guan, PhD, have identified a new protein that helps prevent metastasis of a subset called HER2-positive breast cancer.
February 2, 2022
The University of Cincinnati's Chad Zender is leading a clinical trial studying if using a combination of Cesium-131 radioactive seeds and immunotherapy can be more effective and provide better quality of life than current treatments for patients with recurrent head and neck cancer.
December 7, 2021
The University of Cincinnati's Dr. Vladimir Bogdanov has been awarded a Catalyst Research Award to further investigate if a drug he and his team developed is effective in treating pancreatic cancer.
March 9, 2021
University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, though, with this knowledge, they can continue to aim their targeted treatments at these genes, singularly and together, to stop breast cancer in its tracks.
October 25, 2021
The University of Cincinnati's Dr. Xiaoting Zhang has been awarded a patent for a novel RNA nanoparticle treatment for breast cancer.
October 11, 2021
The University of Cincinnati is opening a new clinical trial looking to see how the combination of immunotherapy and transplant can improve patient outcomes.